Barbara Lelli Selected Research

Peptides (Polypeptides)

1/2019	Peptides and small molecules blocking the CXCR4/CXCL12 axis overcome bone marrow‑induced chemoresistance in acute leukemias.
1/2015	Neurotensin branched peptide as a tumor-targeting agent for human bladder cancer.
6/2013	Cancer selectivity of tetrabranched neurotensin peptides is generated by simultaneous binding to sulfated glycosaminoglycans and protein receptors.
4/2013	Nanoparticles exposing neurotensin tumor-specific drivers.
4/2011	Target-selective drug delivery through liposomes labeled with oligobranched neurotensin peptides.
4/2010	Design and in vitro evaluation of branched peptide conjugates: turning nonspecific cytotoxic drugs into tumor-selective agents.
9/2007	Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting.
4/2006	Stable peptide inhibitors prevent binding of lethal and oedema factors to protective antigen and neutralize anthrax toxin in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Lelli Research Topics

Disease

8	Neoplasms (Cancer) 01/2015 - 09/2007
1	Leukemia 01/2019
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2015
1	Rheumatoid Arthritis 06/2014
1	Melanoma (Melanoma, Malignant) 06/2014
1	Carcinogenesis 06/2012
1	Prostatic Neoplasms (Prostate Cancer) 06/2012
1	Rhabdomyosarcoma 04/2011
1	Colonic Neoplasms (Colon Cancer) 04/2011
1	Schizophrenia (Dementia Praecox) 08/2010
1	Anthrax 04/2006

Drug/Important Bio-Agent (IBA)

8	Peptides (Polypeptides)IBA 01/2019 - 04/2006
6	NeurotensinIBA 01/2015 - 09/2007
2	Liposomes (Liposome)IBA 04/2013 - 04/2011
2	LigandsIBA 06/2012 - 08/2010
1	Factor XII (Hageman Factor)IBA 01/2019
1	PotassiumIBA 01/2019
1	IntegrinsIBA 01/2019
1	Chemokine ReceptorsIBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2015
1	tumor-specific tetrabranched peptide NT4IBA 01/2015
1	Gemcitabine FDA Link 01/2015
1	Adalimumab (Humira)FDA Link 06/2014
1	peptide AIBA 06/2014
1	Monoclonal AntibodiesIBA 06/2014
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 06/2014
1	Proteins (Proteins, Gene)FDA Link 06/2013
1	LDL Receptors (LDL Receptor)IBA 06/2013
1	Heparin (Liquaemin)FDA LinkGeneric 06/2013
1	GlycosaminoglycansIBA 06/2013
1	cholanic acidIBA 06/2012
1	EphA2 ReceptorIBA 06/2012
1	EphrinsIBA 06/2012
1	Neurotensin Receptors (Neurotensin Receptor)IBA 04/2011
1	1,2-oleoylphosphatidylcholine (DOPC)IBA 04/2011
1	Serine (L-Serine)FDA Link 08/2010
1	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 08/2010
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2010
1	Peptide Receptors (Peptide Receptor)IBA 04/2010
1	neurotensin (9-13)IBA 09/2007
1	NeuropeptidesIBA 09/2007
1	AntigensIBA 04/2006

Therapy/Procedure

3	Therapeutics 01/2015 - 09/2007
1	Precision Medicine 06/2013